Fund Overview of Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth
-
₹30.6 CrAUM
-
₹11.67NAV
-
1.04%Expense Ratio
-
EquityFund Category
Minimum amount you can invest: ₹500
Maximum amount you can invest: ₹1,00,000
We have used a return rate of 15% for our calculations.
Returns of Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 12.28% | NA | 6.12% |
| 6 Months | 11.40% | NA | 12.92% |
| 1 Year | 13.92% | 13.92% | 6.04% |
Asset Allocation
equities
100.04%Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth is one Equity mutual fund offered by Motilal Oswal Mutual Fund. Launched on 19 Nov 2024, the fund aims Return that corresponds to the returns of the Nifty MidSmall Healthcare Total Return Index, subject to tracking error. Long term capital growth. It manages assets worth ₹30.6 crore as on Thu Apr 30, 2026. The expense ratio stands at 1.04%. Fund Manager Manager Education Fund Manager Manager Education Fund Manager Manager EducationAbout Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth
The portfolio allocation consists of 100.04% in equities.Managed by Swapnil P Mayekar, it has delivered a return of 13.92% in the last year, a total return since inception of 10.44%.
Considering individual goals investors often review best sip as part of their overall investment planning.
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,323 | 1.83% | 8.84% | 11.42% | 25.97% | 16.61% |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹4,323 | 1.83% | 8.84% | 11.42% | 25.97% | 16.61% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,454 | -0.71% | 9.19% | 6.28% | 27.47% | 16.44% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,454 | -0.71% | 9.19% | 6.28% | 27.47% | 16.44% |
| Mirae Asset Healthcare Fund Direct-growth |
₹2,939 | 1.24% | 8.95% | 14.74% | 26.64% | 16.03% |
| Mirae Asset Healthcare Fund Direct-idcw |
₹2,939 | 1.24% | 8.95% | 14.74% | 26.64% | 16.03% |
| DSP Healthcare Fund Direct-growth |
₹3,142 | 2.91% | 11.39% | 9.07% | 23.47% | 15.58% |
| DSP Healthcare Fund Direct-idcw |
₹3,142 | 2.91% | 11.39% | 9.07% | 23.47% | 15.58% |
| UTI Healthcare Fund Direct-growth |
₹1,217 | 2.48% | 12.24% | 11.95% | 27.51% | 15.42% |
| UTI Healthcare Fund Direct-idcw |
₹1,217 | 2.48% | 12.24% | 11.95% | 27.51% | 15.42% |
More funds from Motilal Oswal Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|---|---|---|---|---|---|
|
Motilal Oswal Bse Healthcare Etf-growth
|
₹42 | 1.49% | 8.80% | 8.10% | 8.91% | 25.35% |
|
Motilal Oswal Nifty Midsmall Healthcare Index Fund Regular-growth
|
₹31 | 1.27% | 12.16% | 11.15% | 13.39% | - |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| Nippon India Pharma Fund-growth |
₹8,365 | ₹536.48 | 21.98% | 12.83% | 15.22% |
| Nippon India Pharma Fund Direct-growth |
₹8,365 | ₹602.32 | 23.08% | 13.85% | 16.25% |
| Nippon India Pharma Fund-idcw |
₹8,365 | ₹115.85 | 21.98% | 12.83% | 15.22% |
| Nippon India Pharma Fund Direct-idcw |
₹8,365 | ₹164.84 | 23.08% | 13.85% | 16.25% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-growth |
₹6,454 | ₹41.17 | 26.41% | 15.42% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹6,454 | ₹44.69 | 27.47% | 16.44% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund-idcw |
₹6,454 | ₹24.02 | 26.41% | 15.42% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹6,454 | ₹26.98 | 27.47% | 16.44% | - |
| SBI Healthcare Opportunities Fund-growth |
₹4,323 | ₹465.41 | 24.66% | 15.39% | 13.12% |
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹4,323 | ₹537.76 | 25.97% | 16.61% | 14.37% |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Max Healthcare Institute Ltd | Healthcare | 15.07% | ₹4.28 Cr |
| Lupin Ltd | Healthcare | 9.88% | ₹3.02 Cr |
| Lupin Ltd | Healthcare | 10.67% | ₹2.96 Cr |
| Fortis Healthcare Ltd | Healthcare | 9.91% | ₹2.93 Cr |
| Fortis Healthcare Ltd | Healthcare | 9.91% | ₹2.93 Cr |
| Lupin Ltd | Healthcare | 10.25% | ₹2.91 Cr |
| Fortis Healthcare Ltd | Healthcare | 9.59% | ₹2.79 Cr |
| Lupin Ltd | Healthcare | 9.33% | ₹2.75 Cr |
| Lupin Ltd | Healthcare | 10.09% | ₹2.69 Cr |
| Lupin Ltd | Healthcare | 9.48% | ₹2.69 Cr |
| Fortis Healthcare Ltd | Healthcare | 8.87% | ₹2.61 Cr |
| Lupin Ltd | Healthcare | 8.83% | ₹2.61 Cr |
| Lupin Ltd | Healthcare | 8.83% | ₹2.61 Cr |
| Fortis Healthcare Ltd | Healthcare | 8.50% | ₹2.60 Cr |
| Fortis Healthcare Ltd | Healthcare | 9.02% | ₹2.56 Cr |
| Lupin Ltd | Healthcare | 8.77% | ₹2.56 Cr |
| Fortis Healthcare Ltd | Healthcare | 8.54% | ₹2.42 Cr |
| Laurus Labs Ltd | Healthcare | 7.57% | ₹2.32 Cr |
| Fortis Healthcare Ltd | Healthcare | 8.57% | ₹2.29 Cr |
| Laurus Labs Ltd | Healthcare | 7.98% | ₹2.26 Cr |
| Laurus Labs Ltd | Healthcare | 7.43% | ₹2.19 Cr |
| Fortis Healthcare Ltd | Healthcare | 7.87% | ₹2.19 Cr |
| Laurus Labs Ltd | Healthcare | 7.68% | ₹2.18 Cr |
| Lupin Ltd | Healthcare | 7.59% | ₹2.15 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.87% | ₹2.10 Cr |
| Fortis Healthcare Ltd | Healthcare | 7.27% | ₹2.06 Cr |
| Laurus Labs Ltd | Healthcare | 6.91% | ₹2.04 Cr |
| Laurus Labs Ltd | Healthcare | 6.91% | ₹2.04 Cr |
| Laurus Labs Ltd | Healthcare | 7.34% | ₹2.04 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 6.40% | ₹1.96 Cr |
| Laurus Labs Ltd | Healthcare | 7.24% | ₹1.94 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.93% | ₹1.92 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.36% | ₹1.87 Cr |
| Laurus Labs Ltd | Healthcare | 6.20% | ₹1.81 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.27% | ₹1.78 Cr |
| Aurobindo Pharma Ltd | Healthcare | 5.94% | ₹1.75 Cr |
| Aurobindo Pharma Ltd | Healthcare | 5.94% | ₹1.75 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.94% | ₹1.75 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.53% | ₹1.74 Cr |
| Aurobindo Pharma Ltd | Healthcare | 6.14% | ₹1.74 Cr |
| Alkem Laboratories Ltd | Healthcare | 6.06% | ₹1.72 Cr |
| Alkem Laboratories Ltd | Healthcare | 6.42% | ₹1.71 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.58% | ₹1.71 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.78% | ₹1.71 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.78% | ₹1.71 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.98% | ₹1.69 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 6.10% | ₹1.69 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.80% | ₹1.69 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.91% | ₹1.68 Cr |
| Aurobindo Pharma Ltd | Healthcare | 5.75% | ₹1.68 Cr |
| Alkem Laboratories Ltd | Healthcare | 5.89% | ₹1.64 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.58% | ₹1.63 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.68% | ₹1.61 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.43% | ₹1.60 Cr |
| Laurus Labs Ltd | Healthcare | 5.57% | ₹1.58 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.87% | ₹1.57 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.29% | ₹1.56 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.29% | ₹1.56 Cr |
| Mankind Pharma Ltd. | Healthcare | 5.22% | ₹1.52 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 5.22% | ₹1.48 Cr |
| Mankind Pharma Ltd. | Healthcare | 5.01% | ₹1.48 Cr |
| Mankind Pharma Ltd. | Healthcare | 5.01% | ₹1.48 Cr |
| Aurobindo Pharma Ltd | Healthcare | 5.19% | ₹1.47 Cr |
| Biocon Ltd | Healthcare | 5.11% | ₹1.45 Cr |
| Biocon Ltd | Healthcare | 4.54% | ₹1.39 Cr |
| Mankind Pharma Ltd. | Healthcare | 4.72% | ₹1.39 Cr |
| Mankind Pharma Ltd. | Healthcare | 4.49% | ₹1.37 Cr |
| Biocon Ltd | Healthcare | 4.90% | ₹1.36 Cr |
| Biocon Ltd | Healthcare | 5.06% | ₹1.35 Cr |
| Mankind Pharma Ltd. | Healthcare | 4.71% | ₹1.34 Cr |
| Mankind Pharma Ltd. | Healthcare | 4.67% | ₹1.33 Cr |
| Mankind Pharma Ltd. | Healthcare | 4.61% | ₹1.31 Cr |
| Biocon Ltd | Healthcare | 4.44% | ₹1.31 Cr |
| Alkem Laboratories Ltd | Healthcare | 4.39% | ₹1.25 Cr |
| Biocon Ltd | Healthcare | 4.39% | ₹1.24 Cr |
| Mankind Pharma Ltd. | Healthcare | 4.64% | ₹1.24 Cr |
| Biocon Ltd | Healthcare | 4.17% | ₹1.23 Cr |
| Biocon Ltd | Healthcare | 4.17% | ₹1.23 Cr |
| Mankind Pharma Ltd. | Healthcare | 4.31% | ₹1.20 Cr |
| Ipca Laboratories Ltd | Healthcare | 4.23% | ₹1.17 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.76% | ₹1.15 Cr |
| Biocon Ltd | Healthcare | 3.89% | ₹1.13 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.90% | ₹1.11 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.75% | ₹1.10 Cr |
| Biocon Ltd | Healthcare | 3.82% | ₹1.08 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.95% | ₹1.06 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.66% | ₹1.04 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.53% | ₹1.03 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.31% | ₹0.98 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.31% | ₹0.98 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.29% | ₹0.97 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.29% | ₹0.97 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.38% | ₹0.96 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.14% | ₹0.96 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.27% | ₹0.95 Cr |
| Ipca Laboratories Ltd | Healthcare | 3.33% | ₹0.95 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.13% | ₹0.92 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.95% | ₹0.90 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 3.22% | ₹0.89 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 3.21% | ₹0.89 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.91% | ₹0.89 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 3.08% | ₹0.88 Cr |
| Gland Pharma Ltd | Healthcare | 3.01% | ₹0.88 Cr |
| Abbott India Ltd | Healthcare | 2.90% | ₹0.85 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 3.00% | ₹0.85 Cr |
| Gland Pharma Ltd | Healthcare | 2.86% | ₹0.84 Cr |
| Gland Pharma Ltd | Healthcare | 2.86% | ₹0.84 Cr |
| Abbott India Ltd | Healthcare | 2.90% | ₹0.84 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.86% | ₹0.84 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.86% | ₹0.84 Cr |
| Abbott India Ltd | Healthcare | 2.80% | ₹0.83 Cr |
| Abbott India Ltd | Healthcare | 2.80% | ₹0.83 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.79% | ₹0.82 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.92% | ₹0.81 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.75% | ₹0.81 Cr |
| Abbott India Ltd | Healthcare | 2.82% | ₹0.80 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.60% | ₹0.80 Cr |
| Abbott India Ltd | Healthcare | 2.80% | ₹0.79 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.80% | ₹0.79 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.79% | ₹0.79 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.95% | ₹0.79 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.67% | ₹0.79 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.69% | ₹0.78 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.76% | ₹0.78 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.62% | ₹0.77 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.62% | ₹0.77 Cr |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | 2.88% | ₹0.77 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.64% | ₹0.77 Cr |
| Gland Pharma Ltd | Healthcare | 2.60% | ₹0.76 Cr |
| Gland Pharma Ltd | Healthcare | 2.84% | ₹0.76 Cr |
| Gland Pharma Ltd | Healthcare | 2.67% | ₹0.76 Cr |
| Gland Pharma Ltd | Healthcare | 2.66% | ₹0.76 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.66% | ₹0.75 Cr |
| Gland Pharma Ltd | Healthcare | 2.46% | ₹0.75 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.55% | ₹0.75 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.55% | ₹0.75 Cr |
| Abbott India Ltd | Healthcare | 2.79% | ₹0.74 Cr |
| Abbott India Ltd | Healthcare | 2.54% | ₹0.72 Cr |
| Gland Pharma Ltd | Healthcare | 2.54% | ₹0.72 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.45% | ₹0.72 Cr |
| Abbott India Ltd | Healthcare | 2.57% | ₹0.71 Cr |
| Gland Pharma Ltd | Healthcare | 2.57% | ₹0.71 Cr |
| Abbott India Ltd | Healthcare | 2.32% | ₹0.71 Cr |
| Sai Life Sciences Ltd. | Healthcare | 2.54% | ₹0.71 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.28% | ₹0.70 Cr |
| Wockhardt Ltd | Healthcare | 2.38% | ₹0.69 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.37% | ₹0.69 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.41% | ₹0.68 Cr |
| Syngene International Ltd | Healthcare | 2.30% | ₹0.68 Cr |
| Syngene International Ltd | Healthcare | 2.30% | ₹0.68 Cr |
| Piramal Pharma Ltd | Healthcare | 2.29% | ₹0.68 Cr |
| Piramal Pharma Ltd | Healthcare | 2.29% | ₹0.68 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.38% | ₹0.68 Cr |
| Syngene International Ltd | Healthcare | 2.28% | ₹0.67 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.48% | ₹0.66 Cr |
| Jb Chemicals & Pharmaceuticals Ltd | Healthcare | 2.33% | ₹0.66 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.16% | ₹0.66 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.23% | ₹0.66 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.23% | ₹0.66 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.32% | ₹0.66 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.26% | ₹0.66 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.22% | ₹0.66 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.22% | ₹0.66 Cr |
| Syngene International Ltd | Healthcare | 2.24% | ₹0.65 Cr |
| Piramal Pharma Ltd | Healthcare | 2.24% | ₹0.65 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.24% | ₹0.65 Cr |
| Syngene International Ltd | Healthcare | 2.29% | ₹0.65 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.28% | ₹0.65 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.10% | ₹0.64 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.16% | ₹0.64 Cr |
| Piramal Pharma Ltd | Healthcare | 2.14% | ₹0.63 Cr |
| Aster Dm Healthcare Ltd | Healthcare | 2.21% | ₹0.63 Cr |
| Wockhardt Ltd | Healthcare | 2.22% | ₹0.63 Cr |
| Syngene International Ltd | Healthcare | 2.20% | ₹0.63 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.25% | ₹0.62 Cr |
| Wockhardt Ltd | Healthcare | 2.04% | ₹0.62 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.13% | ₹0.62 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.32% | ₹0.62 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.16% | ₹0.61 Cr |
| Global Health Ltd | Healthcare | 2.10% | ₹0.61 Cr |
| Global Health Ltd | Healthcare | 2.06% | ₹0.61 Cr |
| Global Health Ltd | Healthcare | 2.06% | ₹0.61 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.09% | ₹0.61 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.27% | ₹0.61 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.13% | ₹0.60 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.12% | ₹0.60 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.11% | ₹0.60 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.01% | ₹0.59 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 2.01% | ₹0.59 Cr |
| Wockhardt Ltd | Healthcare | 2.21% | ₹0.59 Cr |
| Ajanta Pharma Ltd | Healthcare | 2.00% | ₹0.59 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 2.07% | ₹0.59 Cr |
| Wockhardt Ltd | Healthcare | 2.07% | ₹0.59 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.20% | ₹0.59 Cr |
| Narayana Hrudayalaya Ltd | Healthcare | 2.11% | ₹0.59 Cr |
| Wockhardt Ltd | Healthcare | 1.97% | ₹0.58 Cr |
| Wockhardt Ltd | Healthcare | 1.97% | ₹0.58 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.97% | ₹0.58 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.88% | ₹0.58 Cr |
| Global Health Ltd | Healthcare | 1.95% | ₹0.57 Cr |
| Neuland Laboratories Ltd | Healthcare | 2.02% | ₹0.57 Cr |
| Ajanta Pharma Ltd | Healthcare | 1.93% | ₹0.57 Cr |
| Ajanta Pharma Ltd | Healthcare | 1.93% | ₹0.57 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.99% | ₹0.57 Cr |
| Piramal Pharma Ltd | Healthcare | 1.98% | ₹0.56 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 2.11% | ₹0.56 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.93% | ₹0.56 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.90% | ₹0.56 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.90% | ₹0.56 Cr |
| Ajanta Pharma Ltd | Healthcare | 1.92% | ₹0.56 Cr |
| Piramal Pharma Ltd | Healthcare | 1.98% | ₹0.56 Cr |
| Wockhardt Ltd | Healthcare | 1.89% | ₹0.56 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.95% | ₹0.56 Cr |
| Granules India Ltd | Healthcare | 1.79% | ₹0.55 Cr |
| Neuland Laboratories Ltd | Healthcare | 1.97% | ₹0.55 Cr |
| Piramal Pharma Ltd | Healthcare | 1.77% | ₹0.54 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.91% | ₹0.54 Cr |
| Dr. Lal Pathlabs Ltd | Healthcare | 1.94% | ₹0.54 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.90% | ₹0.54 Cr |
| Ajanta Pharma Ltd | Healthcare | 1.88% | ₹0.53 Cr |
| Natco Pharma Ltd | Healthcare | 1.74% | ₹0.53 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.79% | ₹0.53 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.79% | ₹0.53 Cr |
| Global Health Ltd | Healthcare | 1.86% | ₹0.53 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.86% | ₹0.53 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.71% | ₹0.52 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.69% | ₹0.52 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.92% | ₹0.51 Cr |
| Neuland Laboratories Ltd | Healthcare | 1.80% | ₹0.51 Cr |
| Wockhardt Ltd | Healthcare | 1.85% | ₹0.51 Cr |
| Global Health Ltd | Healthcare | 1.67% | ₹0.51 Cr |
| Global Health Ltd | Healthcare | 1.79% | ₹0.51 Cr |
| Piramal Pharma Ltd | Healthcare | 1.77% | ₹0.50 Cr |
| Global Health Ltd | Healthcare | 1.77% | ₹0.50 Cr |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | 1.80% | ₹0.50 Cr |
| Piramal Pharma Ltd | Healthcare | 1.85% | ₹0.49 Cr |
| Syngene International Ltd | Healthcare | 1.57% | ₹0.48 Cr |
| Granules India Ltd | Healthcare | 1.71% | ₹0.48 Cr |
| Syngene International Ltd | Healthcare | 1.74% | ₹0.46 Cr |
| Natco Pharma Ltd | Healthcare | 1.63% | ₹0.46 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.57% | ₹0.46 Cr |
| Natco Pharma Ltd | Healthcare | 1.66% | ₹0.46 Cr |
| Global Health Ltd | Healthcare | 1.72% | ₹0.46 Cr |
| Granules India Ltd | Healthcare | 1.61% | ₹0.46 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.59% | ₹0.45 Cr |
| Granules India Ltd | Healthcare | 1.53% | ₹0.45 Cr |
| Granules India Ltd | Healthcare | 1.53% | ₹0.45 Cr |
| Piramal Pharma Ltd | Healthcare | 1.61% | ₹0.45 Cr |
| Granules India Ltd | Healthcare | 1.55% | ₹0.44 Cr |
| Granules India Ltd | Healthcare | 1.50% | ₹0.44 Cr |
| Pfizer Ltd | Healthcare | 1.47% | ₹0.43 Cr |
| Pfizer Ltd | Healthcare | 1.47% | ₹0.43 Cr |
| Global Health Ltd | Healthcare | 1.55% | ₹0.43 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.55% | ₹0.43 Cr |
| Natco Pharma Ltd | Healthcare | 1.46% | ₹0.43 Cr |
| Granules India Ltd | Healthcare | 1.60% | ₹0.43 Cr |
| Natco Pharma Ltd | Healthcare | 1.50% | ₹0.43 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.39% | ₹0.43 Cr |
| Pfizer Ltd | Healthcare | 1.45% | ₹0.42 Cr |
| Poly Medicure Ltd | Healthcare | 1.42% | ₹0.42 Cr |
| Poly Medicure Ltd | Healthcare | 1.42% | ₹0.42 Cr |
| Syngene International Ltd | Healthcare | 1.47% | ₹0.42 Cr |
| Granules India Ltd | Healthcare | 1.42% | ₹0.41 Cr |
| Pfizer Ltd | Healthcare | 1.40% | ₹0.41 Cr |
| Poly Medicure Ltd | Healthcare | 1.41% | ₹0.41 Cr |
| Poly Medicure Ltd | Healthcare | 1.37% | ₹0.40 Cr |
| Natco Pharma Ltd | Healthcare | 1.36% | ₹0.40 Cr |
| Natco Pharma Ltd | Healthcare | 1.36% | ₹0.40 Cr |
| Pfizer Ltd | Healthcare | 1.41% | ₹0.40 Cr |
| Pfizer Ltd | Healthcare | 1.40% | ₹0.40 Cr |
| Natco Pharma Ltd | Healthcare | 1.39% | ₹0.39 Cr |
| Natco Pharma Ltd | Healthcare | 1.35% | ₹0.39 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.34% | ₹0.39 Cr |
| Syngene International Ltd | Healthcare | 1.41% | ₹0.39 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.37% | ₹0.39 Cr |
| Natco Pharma Ltd | Healthcare | 1.45% | ₹0.39 Cr |
| Pfizer Ltd | Healthcare | 1.26% | ₹0.38 Cr |
| Pfizer Ltd | Healthcare | 1.36% | ₹0.38 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.27% | ₹0.38 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.27% | ₹0.38 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.29% | ₹0.37 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.25% | ₹0.37 Cr |
| Pfizer Ltd | Healthcare | 1.27% | ₹0.36 Cr |
| Pfizer Ltd | Healthcare | 1.34% | ₹0.36 Cr |
| Poly Medicure Ltd | Healthcare | 1.26% | ₹0.36 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.23% | ₹0.35 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.22% | ₹0.35 Cr |
| Onesource Specialty Pharma Ltd | Healthcare | 1.28% | ₹0.34 Cr |
| Poly Medicure Ltd | Healthcare | 1.20% | ₹0.34 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 1.20% | ₹0.32 Cr |
| Granules India Ltd | Healthcare | 1.12% | ₹0.32 Cr |
| Poly Medicure Ltd | Healthcare | 1.02% | ₹0.31 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.09% | ₹0.31 Cr |
| Poly Medicure Ltd | Healthcare | 1.12% | ₹0.30 Cr |
| Rainbow Childrens Medicare Ltd | Healthcare | 1.10% | ₹0.29 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.93% | ₹0.26 Cr |
| Suven Pharmaceuticals Ltd | Healthcare | 0.93% | ₹0.26 Cr |
| Alembic Pharmaceuticals Ltd | Healthcare | 0.89% | ₹0.25 Cr |
| Poly Medicure Ltd | Healthcare | 0.88% | ₹0.25 Cr |
| Poly Medicure Ltd | Healthcare | 0.86% | ₹0.24 Cr |
| Reverse Repo/cblo | Unspecified | 0.40% | ₹0.11 Cr |
| Reverse Repo/cblo | Unspecified | 0.36% | ₹0.11 Cr |
| Net Receivables | Unspecified | 0.34% | ₹0.10 Cr |
| Net Receivables | Unspecified | 0.27% | ₹0.07 Cr |
| Net Receivables | Unspecified | 0.20% | ₹0.05 Cr |
| Net Receivables | Unspecified | 0.16% | ₹0.05 Cr |
| Net Receivables | Unspecified | 0.16% | ₹0.04 Cr |
| Net Receivables | Unspecified | 0.12% | ₹0.04 Cr |
| Net Receivables | Unspecified | 0.12% | ₹0.04 Cr |
| Net Payables | Unspecified | -0.12% | ₹-0.03 Cr |
| Net Payables | Unspecified | -0.21% | ₹-0.06 Cr |
| Net Payables | Unspecified | -0.40% | ₹-0.12 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| SBI Healthcare Opportunities Fund Direct Plan-growth |
₹537.76 | 25.97% | 16.61% | - |
| SBI Healthcare Opportunities Fund Direct Plan-idcw |
₹373.62 | 25.97% | 16.61% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-growth |
₹44.69 | 27.47% | 16.44% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct-idcw |
₹26.98 | 27.47% | 16.44% | - |
| Mirae Asset Healthcare Fund Direct-growth |
₹47.74 | 26.64% | 16.03% | - |
| Mirae Asset Healthcare Fund Direct-idcw |
₹28.75 | 26.64% | 16.03% | - |
| DSP Healthcare Fund Direct-growth |
₹45.92 | 23.47% | 15.58% | - |
| DSP Healthcare Fund Direct-idcw |
₹26.55 | 23.47% | 15.58% | - |
| UTI Healthcare Fund Direct-growth |
₹354.07 | 27.51% | 15.42% | - |
| UTI Healthcare Fund Direct-idcw |
₹273.67 | 27.51% | 15.42% | - |
Frequently Asked Questions
Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth
What is the current AUM of Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth?
As of Thu Apr 30, 2026, Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth manages assets worth ₹30.6 crore
How has Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth performed recently?
- 3 Months: 12.28%
- 6 Months: 11.40%
What is the long-term performance of Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth?
- Since Inception: 10.44%
What is the portfolio composition of Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth?
Equity: 100.04%, Others: -0.04%.
Who manages Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth?
Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth is managed by Swapnil P Mayekar from Motilal Oswal Mutual Fund.
What is the market-cap allocation of Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth?
Mid Cap: 65.42%, Small Cap: 34.58%.
Which are the top companies Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth has invested in?
- Max Healthcare Institute Ltd – 15.07% of the fund's portfolio
- Lupin Ltd – 9.88% of the fund's portfolio
- Lupin Ltd – 10.67% of the fund's portfolio
- Fortis Healthcare Ltd – 9.91% of the fund's portfolio
- Fortis Healthcare Ltd – 9.91% of the fund's portfolio
Which are the major sectors Motilal Oswal Nifty Midsmall Healthcare Index Fund Direct-growth focuses on?
- Healthcare – 998.61% of the fund's portfolio
- Unspecified – 1.39% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.





